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doi:10.1016/j.jmii.2012.03.011Background/Purpose: A T-helper cell type 1-specific response leads to the elimination of intra-
cellular infection with Brucella. Studies have shown that naloxone (NLX) can promote a cellular
immune response in this respect. The current study was carried out to evaluate the induction
of protective immunity in mice against brucellosis by vaccination with a combination of NLX,
alum, and heat-killed Brucella melitensis 16 M (HKB).
Methods: Mice were categorized into five groups and received intraperitoneal vaccination on
Days 0 and 7. Then serum levels of interferon (IFN)-g and interleukin (IL)-4, the bacterial load,
and the survival rate were measured 2 weeks after the last vaccination.
Results: The serum levels of IFN-g, IL-4, and immunoglobulin G in the NLX þ alum þ HKB group
were shown to be significantly increased (p < 0.05). Furthermore, the lowest bacterial load
was observed in this group. The survival rate in groups vaccinated with combinations contain-
ing adjuvants was 100%.of Immunology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
l.com (M.R. Rahmani).
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254 Y. Motaharinia et al.Conclusion: The combination of NLX and alum enhanced the immunogenicity of HKB, which
can be used in the vaccination of animals and humans at risk of the disease.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction solution and then incubated at 65 C for 60 minutes. The
solution was evaluated, and it was confirmed that theBrucella melitensis is the most pathogenic Brucella species
in human. The bacterium is the cause of abortion in ewes,
which leads to a considerable economic loss in most coun-
tries.1 Brucella melitensis Rev1 is the vaccine available for
the prevention of brucellosis in sheep and goats in endemic
areas, producing a higher protective immunity than the
killed vaccine. However, in a few cases, the vaccine has led
to brucellosis in humans and animals.2
In brucellosis infection, macrophages phagocytose the
Brucella bacteria, which grow and propagate in the
macrophages. During the infection, interferon (IFN)-g is
the most important factor for the activation of macro-
phages to kill the intracellular Brucella.3 A T-helper cell
type 1 (Th1)-specific response leads to the elimination of
intracellular infections of Brucella, while an expansion of
the Th2 response is observed in prolonged infections.4,5
Brucella infection can lead to aberrations of the
immune system and Th1-specific responses to the
infection.6
Alum is a commonly used adjuvant.7 In addition, recent
studies have shown that naloxone (NLX) can increase the
level of IFN-g and promote the immune response to
produce a Th1 pattern.8 It has been show that, in infection
caused by intracellular bacteria such as Listeria mono-
cytogenes, NLX can stimulate IFN-g production and lead to
stronger cell-mediated immunity.9 Therefore, the aim of
the current study was to evaluate the effect of NLX and
alum together with whole killed B. melitensis 16 M in the
development of cellular immunity against the bacterium in
mice.
Methods
Bacteria
The strain of B. melitensis 16 M used was obtained from the
Microbiology Research Center, Islamic Azad University,
Zanjan Branch, Iran.
Mice
The experiments were performed according to the Helsinki
guidelines. Male BALB/c mice with a mean age of 6e8
weeks were bought from Razi Institute (Karaj, Iran) and
received autoclaved water and food.
Preparation of whole killed Brucella melitensis 16 M
The bacterium was cultured on Brucella agar (Merck,
Darmstadt Germany) and inoculated at 37C for 3e5 days.
The colonies were collected and they were washed three
times with phosphate-buffered saline (PBS) solution. The
precipitated bacteria were again mixed with the PBS
bacteria were unable to grow. The number of bacteria was
measured by comparing serial concentration absorptions at
a wavelength of 590 nm.10
Immunization of mice
The combination of NLX þ alum was prepared by mixing
50 mL of PBS, which contained 6 mg/kg NLX (Sigma,
Ansbach, Germany), with 50 mL of aluminum phosphate gel
(Sigma). The mice were categorized into five groups and
received intraperitoneal (i.p.) vaccine on Days 0 and 7. The
first group received a combination of heat-killed B. meli-
tensis [HKB; at a dose of 108 colony-forming units
(CFUs)] þ alum þ NLX; the second group was vaccinated
with a combination of HKB þ alum; the third group received
HKB þ NLX; the fourth group received HKB; and the fifth
group, as the control group, received only sterile PBS.11
Serum collection
Anesthesia was induced in the mice using i.p. injection of
sodium pentobarbital (80 mg/kg). After anesthesia, blood
samples were taken, and the sera were kept at e70C until
use.12
Evaluation of serum immunoglobulin G
Two weeks after the last vaccination, the immunoglobulin
G (IgG) level in serum samples obtained from five mice from
each group was measured. Measurement was performed
using indirect enzyme-linked immunosorbent assay (ELISA).
A sample of 25 mg sonicated whole-cell antigen of
B.melitensis16Mtogetherwithcarbonatebuffer (pH9.6)was
added to each well of a 96-well plate (SPL, Pocheon, Korea).
The plate was stored overnight at under 4C. The wells were
thenwashed three timeswith PBS-Tween. A blocking stepwas
carried out using PBS containing bovine serum albumin (BSA)
1%, andafterwards thefinal solutionwas incubatedat 37C for
2 hours.
Afterwards, the wells were washed five times, and 50 mL
of horseradish peroxidase (HRP)-conjugated goat anti-
mouse IgG (Millipore, Billerica, Massachusetts, USA), at
a concentration of 1:10,000, was added to each well.
Before adding Tetramethylbenzidine (TMB) substrate (U-
CyTech, Utrecht, The Netherlands), the wells were washed
four times, the plate then being incubated at 37C for 20
minutes. A total of 50 mL of H2SO4 (1 M) was added to
terminate the reaction. Finally, the optical density (OD)
value was read at a wavelength of 450 nm using an ELISA
reader (Awareness, Palm City, USA).11
Measurement of cytokine levels
Five mice were selected from each group and intraperito-
neally challenged with 2  104 CFU living B. melitensis 16 M
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obtained 48 hours after the challenge, and levels of IFN-g
and interleukin (IL)-4 were measured using the sandwich
ELISA method according to the protocol defined for the
commercial kit (Mabtech, Stockholm, Sweden).12Determination of bacterial load in spleen using
real-time polymerase chain reaction
Two weeks after the last vaccination, five mice from each
group were challenged with 2  104 CFU of the bacteria;
48 hours after the challenge, the animals were killed and
their spleens were resected. Using a DNA extraction kit
(Gnet Bio, Nonsan, Korea), DNA was extracted from 30 mg
of spleen tissue for each mouse. The amount of DNA
extracted was determined by spectrophotometry and
measuring the OD ratio A260/A280, and its quality was
evaluated using 1% agarose gel electrophoresis.
The bacterial load in mouse spleen tissue was deter-
mined using primers specifically designed for the genome
segment common among different strains of Brucella with
the following sequences: F, 5’-CCAGCGCACCATCTTTCAG-
3’; and R, 5’-TCGTTGCGCGTAAGGATGC-3’. To prepare the
standard curve, we used 0.5 McFarland B. melitensis 16 M
diluted to 1:100 with sterile distilled water. Using a DNA
extraction kit (Cinnagen, Tehran, Iran), bacterial DNA was
extracted, and the sample was then diluted 10 times to
obtain a range of bacterial presence from 1.5  106 to
15  106 bacteria per mL (Fig. 1).
For the polymerase chain reaction (PCR) process, Master
mix (Pars Tous, Mashhad, Iran), 0.5 mL of each primer, 0.5
mL of SYBR Green (Sigma), and 1 mL of DNA sample in a total
volume of 20 mL were used. The PCR process included the
following steps: primary denaturation at 94C for 10
minutes, and reaction cycles of 94C for 30 seconds, 63C
for 30 seconds, 72C for 45 seconds, and finally 72C for 5
minutes. The reactions were carried out using a Corbett
Rotor-Gene 6000 (Corbett Life Science, Mannheim,
Germany). At the end of the reaction, the melting curve
program was run at 72e94C, and the curve was drawn by
the instrument.13e15Figure 1. Mean serum level (pg/mL) of interferon (IFN)-g in
the groups under evaluation 2 weeks after their last vaccina-
tion. Alum Z aluminum phosphate gel; HKB Z heat-killed
Brucella melitensis 16 M; NLX Z naloxone; PBS Z phosphate
buffered saline.Determination of survival rate
Ten mice received 5  109 CFU (i.p.) living B. melitensis 16
M. After 72 hours, all 10 mice had died, so this value was
determined to be the lethal dose (LD100). Two weeks after
the last vaccination, five mice from each group were
intraperitoneally challenged with the lethal dose.16Statistical analysis
Statistical analysis was performed using SPSS software,
version 12.0 (SPSS Inc, Chicago, Ilinois, USA). Group
comparisons were carried out using ManneWhitney U test.
A p value 0.05 was considered statistically significant.Results
Cytokine level
The highest level of IFN-g was seen in the
NLX þ alum þ HKB group (Fig. 1). The IFN-g level in this
group was significantly higher than in other groups
(pZ 0.009). In addition, the IFN-g level in the alum þ HKB
group was lower than that in the NLX þ HKB group, although
the difference was not significant (pZ 0.34). Moreover, the
difference between the alum þ HKB and HKB groups was
not significant (p Z 0.75). Similarly, the difference
observed between the NLX þ HKB and HKB groups in this
respect was not significant (p Z 0.17). The IFN-g levels in
all the vaccinated groups were higher than the level in the
control group (p < 0.01) (Fig. 1).
The results also showed that the IL-4 level in the
NLX þ alum þ HKB group was significantly higher than the
levels in the alum þ HKB, NLX þ HKB, and control groups
(p < 0.01), as well as the HKB group (p Z 0.04). The IL-4
level in the alum þ HKB group was less than that in the
NLX þ HKB group, but the difference was not significant
(pZ 0.10). The IL-4 level in the alum þ HKB group was less
than that in the HKB group (p < 0.01). A comparison of
NLX þ HKB with HKB demonstrated that the HKB group had
a higher level of IL-4, but the difference was not significant
(p Z 0.2). Finally, the serum level of IL-4 in the control
group was significantly lower than the values obtained for
other groups (p < 0.05) (Fig. 2).Serum IgG titer
The antibody titer in the NLX þ alum þ HKB group was
higher than the values obtained for the other groups.
Compared with the titer in the alum þ HKB group, the
difference was significant (p Z 0.012). A significant
difference was observed between the IgG level in the
NLX þ alum þ HKB group and the NLX þ HKB, HKB, and
control groups (p < 0.05) (Fig. 3). Comparison of the anti-
body level in the other groups demonstrated that other
groups differed in this respect. However, the difference
was not significant, although the difference between the
vaccinated group and control group was significant
(p < 0.01). Nevertheless, other vaccinated groups were not
Figure 4. Bacterial load of Brucella melitensis (number of
bacteria in 30 mg of mouse spleen) in the spleens of mice from
different groups 48 hours after challenge with living bacteria
(2  104 colony-forming units), determined using the real-time
polymerase chain reaction. The bacterial load in the
NLX þ alum þ HKB group was lower than that in the HKB and
control groups (p < 0.01), and in the alum þ HKB and
NLX þ HKB groups. Alum Z aluminum phosphate gel;
HKB Z heat-killed Brucella melitensis 16 M; NLX Z naloxone;
PBS Z phosphate buffered saline.
Figure 2. Mean serum level (pg/mL) of interleukin (IL)-4 in
the groups under evaluation 2 weeks after last vaccination.
Alum Z aluminum phosphate gel; HKB Z heat-killed Brucella
melitensis 16 M; NLX Z naloxone; PBS Z phosphate buffered
saline.
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(Fig. 3).
Bacterial load in spleen
The bacterial load in the NLX þ alum þ HKB group was
lower than the load in the HKB and control groups
(p < 0.01). Moreover, the bacterial load in the
NLX þ alum þ HKB group was lower than those in the
alum þ HKB and NLX þ HKB groups, although the difference
was not significant (p > 0.05). The bacterial loads in the
alum þ HKB and NLX þ HKB groups were significantly lower
than those in the HKB and control groups (p < 0.01). The
bacterial load in the HKB group was less than that in the
control group (p < 0.01) (Fig. 4).
Survival rate of mice after challenge
All mice in the control group had died by 72 hours. More-
over, one mouse from the HKB group died 96 hours after
challenge. All the mice from the other groups survived until
2 weeks after the challenge (Fig. 5).Figure 3. Mean serum level of immunoglobulin G (IgG)
against Brucella melitensis in different groups 2 weeks after
the last vaccination, shown in terms of optical density (OD).
Alum Z aluminum phosphate gel; HKB Z heat-killed Brucella
melitensis 16 M; NLX Z naloxone; PBS Z phosphate buffered
saline.Discussion
The findings showed that a combination of NLX, alum, and
whole HKB increased levels of IFN-g and IL-4 and the
specific IgG against B. melitensis 16 M. Jazani et al11 re-
ported that a group of mice vaccinated with a combination
of alum, NLX, and Lipopolysaccharide (LPS)-removed lysate
of Salmonella typhimurium showed a significant increase in
IFN-g level. Furthermore, they found that the highest level
of IL-4 was observed in the group vaccinated with alum and
lysate of S. typhimurium. In the current study, a significant
increase in IFN-g level was observed in the
NLX þ alum þ HKB group; however, all vaccinated groups
showed a significant difference compared with the control
group. The highest level of IL-4 production was observed in
the NLX þ alum þ HKB group, and the lowest level of IL-4
was observed in the control group, with the second
lowest level in the alum þ HKB group. It should be noted
that IFN-g and IL-4 levels were measured using the serum
level.
In a study carried out by Wang et al,17 the immunoge-
nicity of a mutant strain of B. melitensis 16 M was
compared with that of the vaccinal strain Rev1. These
authors showed a significantly increased IFN-g level in the
groups vaccinated with a mutant strain of B. melitensis 16
M and the vaccinal strain Rev1; however, the values in the
two vaccinated groups were not significantly different.
These results indicate that using different mutants of B.
melitensis did not have a significant effect on the stimu-
lation of IFN-g production.
In the study published by Al-Mariri,18 the immunoge-
nicity of P39 protein of Brucella expressed in Escherichia
coli was evaluated. The results of cytokine evaluation
demonstrated that the IFN-g level in the group vaccinated
with living E. coli expressing P39 protein was higher than
that in the control group. Moreover, stimulation of
lymphocytes of the control group with B. melitensis 16 M
showed an increase in the level of IFN-g, which was lower
Figure 5. Survival rate of mice after challenging five mice from each group with 5  109 colony-forming units (LD100) of living
bacteria. Alum Z aluminum phosphate gel; HKB Z heat-killed Brucella melitensis 16 M; NLX Z naloxone; PBS Z phosphate
buffered saline.
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current study, the levels of IFN-g in the vaccinated groups,
particularly the group vaccinated with NLX þ alum þ HKB,
were higher than that in the control group.
Previous studies have shown that, because of the low
immunogenicity of recombinant proteins from pathogenic
bacteria, the appropriate technique for the production of
vaccines is to employ complete and intact antigens.19 This
is true for the vaccine against B. melitensis. Most vacci-
nation programs for domestic animals are based upon
employment of vaccinal strain Rev1.20 Therefore, studies
to reduce the problems associated with this type of
vaccine and also improve its immunogenicity are of great
importance.
Considering the serum-specific IgG level in the study by
Jazani et al, the highest level of specific IgG was detected
in the alum, NLX, and LPS-removed lysate of S. typhimu-
rium group.11 Wang et al reported that the serum IgG levels
increased significantly in groups vaccinated with mutant B.
melitensis 16 M and Rev1 strain.17 According to our findings,
the serum level of IgG in the NLX þ alum þ HKB group was
significantly higher than that in other groups. Moreover, the
IgG levels in all vaccinated groups were significantly higher
than in the control group.
We preferred to use the specific and sensitive method
of real-time PCR to determine the bacterial load in the
spleens of the mice in our study.20 The lowest bacterial
load was identified in the spleens of the groups vacci-
nated with NLX þ alum þ HKB, and then NLX þ HKB.
Jazani et al was reported that the bacterial load
measured in spleens from the groups vaccinated with
a combination of NLX, alum, and the vaccine, and with
NLX plus the vaccine, were significantly lower than in the
control group.11 In this respect, the results of Wang
et al’s study demonstrated that the bacterial load in the
group vaccinated with mutant B. melitensis 16 M was
reduced, and showed its difference compared with the
control group.17 Furthermore, Al-Mariri showed that
the bacterial load decreased, albeit not significantly, in
the groups vaccinated with E. coli expressing P39. In
addition, the bacterial load in these groups was higher
than that in spleens of mice vaccinated with vaccinal
strain Rev1.18The previously performed studies have shown that
secretion of IFN-g in the early stages of Brucella infection
plays an important role in limiting and eliminating the
bacteria via macrophage activation.21 According to the
results obtained, using a combination of NLX þ alum þ HKB
as a vaccine was strongly effective in reducing the bacterial
load in vaccinated mice. It was observed that vaccination
with NLX þ alum þ HKB was able to establish 100% protec-
tive immunity against the lethal dose of the bacteria. The
current study showed that using NLX and alum, as adju-
vants, together with whole killed B. melitensis can enhance
the cellular immunity response.
NLX and alum have been routinely administered to
humans. In addition, the whole killed cells used in the study
do not carry a risk of pathogenicity, and the cost of vaccine
production in this method is low. Hence, it is hoped that the
combination could be used in future vaccines prepared for
domestic animals and even humans.Conflicts of interest
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